Compare ImmunityBio Inc. Common Stock (IBRX) vs MACOM Technology (MTSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs MACOM Technology — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while MACOM Technology trades at $330.1 (market cap $25.65B). The key difference: MACOM Technology is far larger — about 2.5× ImmunityBio Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, MACOM Technology nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and MACOM Technology for 6 Days on average.
| IBRX | MTSI | |
|---|---|---|
Market Cap | $10.33B | $25.65B |
Volume | 11,745,198 | 1,518,856 |
Sector | Health | Technology |
52-Week High | $11.55 | $409.68 |
52-Week Low | $1.98 | $122.18 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $10.79B | $25.37B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About MACOM Technology
MACOM develops analog, radio frequency, microwave, and optical semiconductors. Its components are used in telecommunications, data centers, industrial systems, aerospace, and defense applications.
Read more on MTSI →
